Rapid and Visual Detection of Muscovy Duck Reovirus Using a Reverse Transcription Recombinase‐Aided Amplification Assay in a Lyophilized Format for Point‐of‐Care Applications
Transboundary and Emerging Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/tbed/5924181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 25.02.2026. Verfasst von Xiuqin Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Science, Fuzhou, Fujian, 350013, China, faas.cn. Hauptthemen laut MEDLINE: Orthoreovirus, Avian, Reoviridae Infections, Ducks, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Academy of Agricultural Sciences, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Muscovy duck reovirus (MDRV) causes substantial economic losses in the waterfowl industry, necessitating rapid and field‐deployable diagnostic tools. In this study, we developed, for the first time, a lyophilized reagent‐based reverse transcription recombinase‐aided amplification (RT‐RAA) assay targeting the σC gene of MDRV for point‐of‐care testing (POCT). The assay was optimized to operate at 39°C with a probe concentration of 100 nM. It achieved a detection limit of 1.03 × 10 1 copies/μL within 20 min, which is comparable to RT‐quantitative polymerase chain reaction (qPCR) and superior to existing methods. It exhibited high specificity for MDRV with no cross‐reactivity against other common waterfowl pathogens. Particularly, the assay was successfully lyophilized into a ready‐to‐use format, representing the first reported RT‐RAA‐based method for MDRV detection in such a format. The lyophilized reagents retained the key analytical performance characteristics without cold‐chain dependance. When evaluated on 42 clinical samples, the lyophilized RT‐RAA demonstrated 95.8% diagnostic sensitivity and 100% specificity compared to RT‐qPCR, with almost perfect agreement ( κ = 0.952). A visual readout using a portable blue light imager further enabled naked‐eye interpretation without instrumentation. This robust, rapid, and field‐deployable RT‐RAA assay provides a practical solution for on‐site MDRV surveillance, particularly in low‐resource settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Science, Fuzhou, Fujian, 350013, China, faas.cn.
- Fujian Animal Diseases Control Technology Development Center, Fuzhou, 350013, Fujian, China, faas.cn.
- Longwen District Animal Disease Control Center, Zhangzhou, 363000, Fujian, China.
ORCID-Profile: Xiuqin Chen, Shizhong Zhang, Xiaochun Luo, Guangju You, Shaoying Chen, Meiqing Huang, Shao Wang, Shilong Chen
Förderung
- Fujian Academy of Agricultural Sciences
- Natural Science Foundation of Fujian Province
Zitieren
APA
Chen, X., Zhang, S., Luo, X., You, G., Chen, S., Huang, M., Wang, S., & Chen, S. (2026). Rapid and Visual Detection of Muscovy Duck Reovirus Using a Reverse Transcription Recombinase‐Aided Amplification Assay in a Lyophilized Format for Point‐of‐Care Applications. Transboundary and Emerging Diseases, 2026(1). https://doi.org/10.1155/tbed/5924181
Vancouver
Chen X, Zhang S, Luo X, You G, Chen S, Huang M, et al. Rapid and Visual Detection of Muscovy Duck Reovirus Using a Reverse Transcription Recombinase‐Aided Amplification Assay in a Lyophilized Format for Point‐of‐Care Applications. Transboundary and Emerging Diseases. 2026;2026(1). doi:10.1155/tbed/5924181
BibTeX
@article{Chen2026,
author = {Chen, Xiuqin and Zhang, Shizhong and Luo, Xiaochun and You, Guangju and Chen, Shaoying and Huang, Meiqing and Wang, Shao and Chen, Shilong},
title = {Rapid and Visual Detection of Muscovy Duck Reovirus Using a Reverse Transcription Recombinase‐Aided Amplification Assay in a Lyophilized Format for Point‐of‐Care Applications},
journal = {Transboundary and Emerging Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/tbed/5924181}
}
EUVIMED